Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Tissue engineering advancements are improving skin substitutes for better burn treatment.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Human pluripotent stem cells could be used to make platelets for medical use, but safety, effectiveness, and cost issues need to be resolved.

cGVHD often severely affects the skin, causing rapid aging and other issues.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Platelet concentrates are useful for tissue repair in medicine and dentistry, with L-PRF showing promising results in various treatments.

Adult mesenchymal stem cells show promise in improving tendon, muscle, and skin healing.

Unmodified mesenchymal stem cells have limited benefits, so ongoing research aims to improve their effectiveness.

Mesenchymal stem cells are effective and safe for treating various diseases in children.

Adult mesenchymal stem cells can help regenerate tissues and are promising for healing bones, wounds, and hair follicles.

Exosomes from mesenchymal stem cells show promise for tissue repair but face challenges in isolation and safety testing.